Invasive Cardiology

RSS Feeds

Digital Edition

DIGITAL EDITION

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »





CLINICAL EVENTS CALENDAR

Non-Accredited Education

CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.

Challenging Closure of a Patent Foramen Ovale via a Superior Approach

(A) Balloon sizing of the patent foramen ovale (PFO) in the
AP projection, with localization of the PFO (arrow) and illustration of
distorted anatomy. (B) Deployment of the Amplatzer device (arrow).
(C) Right atrial injection showing the Amplatzer device



VOLUME: 20 PUBLICATION DATE: Jan 24 2008
Sidebars_in_article: 
Issue Number: 
1 (Jan 2008)
author(s): 

*Ravinay Bhindi, MBBS, PhD, FRACP, FESC, §Neil Wilson, MBBS, FRCP, *Oliver J. Ormerod, DM, FRCP

This case describes the closure of a patent foramen ovale (PFO) via the right internal jugular (IJ) vein in a young patient with an interrupted inferior vena cava (IVC) awaiting liver transplantation.
Case Report. A 25-year-old male with chronic liver failure due to Budd Chiari syndrome had a PFO discovered on contrast echocardiography as part of his transplantation workup. He was subsequently referred by the transplant team for PFO closure prior to liver transplantation to avoid the potential for intraoperative paradoxical embolism.
As the IVC was known to be thrombosed, the right IJ vein was used for vascular access. Following sedation, the right IJ vein was cannulated using a modified Seldinger technique and a 12 Fr sheath was inserted. Routine cardiac imaging options were restricted in this case: intracardiac echocardiography vascular access was limited to the contralateral jugular vein, however, dual-neck vascular catheterization was deemed inappropriate because of the risk of bleeding causing asphyxiation. In addition, transesophageal echocardiography (TEE) was not performed because of esophageal varices, while transthoracic imaging, which was performed, provided poor echocardiographic windows because of anatomic distortion from ascites.

Balloon sizing of the defect (Figure A) performed during the case facilitated fluoroscopic localization of the defect as the heart was rotated by pleural effusions and ascites making interpretation of standard fluoroscopic landmarks difficult. It proved difficult to cross the PFO, and this was finally achieved with a 3.5 left Judkins catheter. Monorail advancement of a Helex delivery system was not technically possible, thus a long 9 Fr Mullins sheath was advanced into the left atrium and a 7 mm Amplatzer atrial septal defect (ASD) device was successfully deployed (Figure B) with a good final result (Figure C).
Percutaneous repair of intracardiac lesions is being increasingly performed, and as such, the operator is likely to be confronted with the prospect of more complex cases. The utilization of the IJ vein to close a PFO has been reported only in a limited number of cases in the literature,1 usually with the assistance of TEE. Although the Amplatzer ASD device is not presently FDA-approved for this indication, this case illustrates a challenging PFO closure performed using a nonconventional vascular access site in a setting further complicated by limited imaging assistance.

References: 

Reference
1. Sader MA, De Moor M, Pomerantsev E, Palacios IF. Percutaneous transcatheter patent foramen ovale closure using the right internal jugular venous approach. Catheter Cardiovasc Interv 2003;60:536–539.

No votes yet


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd><br><h1><h2><h3><b><i>
  • Lines and paragraphs break automatically.

More information about formatting options



Cardiology Blogs

All Subscriptions are FREE to qualified cardiology professionals

#

  • Subscribe to:
  • Journal
  • Digital Journal
  • E-News
  • RSS feed

CLICK HERE TO CONTINUE »

Newly Revised and Updated for 2009!

practical EP



Press Release


FDA Clears Invatec's Mo.Ma Ultra Proximal Cerebral Protection Device

— Bethlehem, Pennsylvania – Invatec received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October to market its Mo.Ma Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS). The device effectively reduces and captures debris released during the stenting procedure to prevent it from traveling to the brain, where it has the potential to cause a stroke.


CME Showcase


The Use of Remote Robotic Navigation
in Complex Arrhythmias

Complimentary Accredited Web Archive
This activity is designed for electrophysiologists and EP allied professionals.

Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions

Complimentary accredited web archive
This activity is intended for physicians, nurses, and technologists.



New Standards of Care for CRMD Antibiotic Protection
Complimentary CME Accredited Webcast
Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET
This activity is sponsored by the North American Center for Continuing Medical Education.

REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.

  • CathLab Digest
  • EP Lab Digest
  • Vascular Disease Management

Web Analytics